The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Michael Michael

Division of Cancer Medicine

Peter MacCallum Cancer Centre

Locked Bag 1

A'Beckett St

Australia

[email]@petermac.org

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Division of Cancer Medicine, Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett St, Australia. 2005 - 2013
  • Peter MacCallum Cancer Centre, Consultant Medical Oncologist, Division of Haematology and Medical Oncology, Chair of GI Clinical Service, Australia. 2010
  • Department of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, Ontario, Canada. 2004

References

  1. A phase I trial of imatinib in combination with mFOLFOX6-bevacizumab in patients with advanced colorectal cancer. Michael, M., Zalcberg, J., Gibbs, P., Lipton, L., Gouillou, M., Jefford, M., McArthur, G., Copeman, M., Lynch, K., Tebbutt, N.C. Cancer Chemother. Pharmacol. (2013) [Pubmed]
  2. Docetaxel pharmacokinetics and its correlation with two in vivo probes for cytochrome P450 enzymes: the C(14)-erythromycin breath test and the antipyrine clearance test. Michael, M., Cullinane, C., Hatzimihalis, A., O'Kane, C., Milner, A., Booth, R., Schlicht, S., Clarke, S.J., Francis, P. Cancer Chemother. Pharmacol. (2012) [Pubmed]
  3. Phase Ib study of CP-868,596, a PDGFR inhibitor, combined with docetaxel with or without axitinib, a VEGFR inhibitor. Michael, M., Vlahovic, G., Khamly, K., Pierce, K.J., Guo, F., Olszanski, A.J. Br. J. Cancer (2010) [Pubmed]
  4. A phase I trial of Capecitabine+Gemcitabine with radical radiation for locally advanced pancreatic cancer. Michael, M., Price, T., Ngan, S.Y., Ganju, V., Strickland, A.H., Muller, A., Khamly, K., Milner, A.D., Dilulio, J., Matera, A., Zalcberg, J.R., Leong, T. Br. J. Cancer (2009) [Pubmed]
  5. Open-label phase I trial of vandetanib in combination with mFOLFOX6 in patients with advanced colorectal cancer. Michael, M., Gibbs, P., Smith, R., Godwood, A., Oliver, S., Tebbutt, N. Invest. New. Drugs (2009) [Pubmed]
  6. Drug metabolism by tumours: its nature, relevance and therapeutic implications. Michael, M., Doherty, M.M. Expert. Opin. Drug. Metab. Toxicol (2007) [Pubmed]
  7. Relationship of hepatic functional imaging to irinotecan pharmacokinetics and genetic parameters of drug elimination. Michael, M., Thompson, M., Hicks, R.J., Mitchell, P.L., Ellis, A., Milner, A.D., Di Iulio, J., Scott, A.M., Gurtler, V., Hoskins, J.M., Clarke, S.J., Tebbut, N.C., Foo, K., Jefford, M., Zalcberg, J.R. J. Clin. Oncol. (2006) [Pubmed]
  8. Prognostic factors predictive of response and survival to a modified FOLFOX regimen: importance of an increased neutrophil count. Michael, M., Goldstein, D., Clarke, S.J., Milner, A.D., Beale, P., Friedlander, M., Mitchell, P. Clin. Colorectal. Cancer (2006) [Pubmed]
  9. Tumoral drug metabolism: overview and its implications for cancer therapy. Michael, M., Doherty, M.M. J. Clin. Oncol. (2005) [Pubmed]
  10. A phase I trial of high-dose palliative radiotherapy plus concurrent weekly Vinorelbine and Cisplatin in patients with locally advanced and metastatic NSCLC. Michael, M., Wirth, A., Ball, D.L., MacManus, M., Rischin, D., Mileshkin, L., Solomon, B., McKendrick, J., Milner, A.D. Br. J. Cancer (2005) [Pubmed]
  11. Phase II study of activated charcoal to prevent irinotecan-induced diarrhea. Michael, M., Brittain, M., Nagai, J., Feld, R., Hedley, D., Oza, A., Siu, L., Moore, M.J. J. Clin. Oncol. (2004) [Pubmed]
 
WikiGenes - Universities